Cardiofront Logo
Jafib Logo
St. Jude Medical

September 02nd, 2014
Submit Manuscript
AF Literature Database
Search Knowledgebase by
Author Last name starts with
B. Weijs(4)Asirvatham Samuel J SJ(3)Alan S. Go, MD(3)
Charlotte Eitel, MD(3)Ayman A. Hussein, MD(3)Blanke Philipp P(2)
Anné Wim W(2)Chamberlain AM(2)Berenfeld Omer O(2)
Caputo M(2)Chao TF(2)Chen Peng-Sheng PS(2)
Andrade JG(2)Akira Fukui, MD(2)Albert Nancy M NM(2)
Ajay K Jain(2)Cook G Elliott GE(2)Botto GL(2)
Bokeriia L A LA(2)Casella M(2)Antonio Hernández-Madrid(2)
Christian Sohns(2)Bengt Zöller(2)Badger Troy J TJ(2)
Charlotte Eitel(2)Billeci Antonia M R AM(1)Aves Theresa T(1)
Chemello D D(1)Aktas Mehmet K MK(1)Andersson Charlotte C(1)
Bruegger D(1)Alan S. Go, MD;(1)Chilukuri Karuna K(1)
Craiglow Brittany B(1)Biviano Angelo A(1)Cakulev Ivan I(1)
Bunch T Jared TJ(1)Contreras-Valdes FM(1)Alexander Wutzler(1)
Cao Fei-fei FF(1)Bungard Tammy J TJ(1)Butcher Kenneth K(1)
Bonvini R F RF(1)A. John Camm, MD(1)Alison Beauchamp(1)
Barry A(1)Boldt Leif-Hendrik LH(1)Cleland John G F JG(1)
Berry Jarett D JD(1)Al-Khatib Sana M SM(1)
Literature Related to Edvardsson NG [Author]
[1]
Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?
Authors : Heidarsdottir Ragnhildur R; Arnar David O DO; Skuladottir Gudrun V GV; Torfason Bjarni B; Edvardsson Vidar V; Gottskalksson Gizur G; Palsson Runolfur R; Indridason Olafur S OS;
Affiliation : Department of Physiology, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Journal : Europace   (2010)
Related Links: Pubmed | Publisher website
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference
Authors :
Affiliation : Tel: +49 251 8345185; fax: +49 251 8345185, Email: kirchhp@uni-muenster.de
Journal : N/A   (2011)
Related Links: Pubmed | Publisher website
Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?
Authors : Heidarsdottir R; Arnar DO; Skuladottir GV; Torfason B; Edvardsson V; Gottskalksson G; Palsson R;
Affiliation : Division of Nephrology, Landspitali University Hospital, Office 14-F, Hringbraut, 101 Reykjavik, Iceland. Tel: +354 543 1000; fax: +354 543 4806. E-mail address: olasi@landspitali.is
Journal : EP Europace   (2010)
Related Links: Pubmed | Publisher website
Pharmacological cardioversion of atrial fibrillation—a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously
Authors : Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N;
Affiliation : Department of Cardiology, Péterfy Hospital, Budapest, Hungary. Tel: +46 31 776 1000; fax: +46 31 776 3737 Email: anders.r.berggren@astrazeneca.com
Journal : Eurpopace   (2011)
Related Links: Pubmed | Publisher website
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.
Authors : Kirchhof P; Lip GY; Van Gelder IC; Bax J; Hylek E; Kaab S; Schotten U; Wegscheider K; Boriani G; Brandes A; Ezekowitz M; Diener H; Haegeli L; Heidbuchel H; Lane D; Mont L; Willems S; Dorian P; Aunes-Jansson M; Blomstrom-Lundqvist C; Borentain M; Breitenstein S; Brueckmann M; Cater N; Clemens A; Dobrev D; Dubner S; Edvardsson NG; Friberg L; Goette A; Gulizia M; Hatala R; Horwood J; Szumowski L; Kappenberger L; Kautzner J; Leute A; Lobban T; Meyer R; Millerhagen J; Morgan J; Muenzel F; Nabauer M; Baertels C; Oeff M; Paar D; Polifka J; Ravens U; Rosin L; Stegink W; Steinbeck G; Vardas P; Vincent A; Walter M; Breithardt G;
Affiliation : University Hospital Münster, Münster, Germany. Corresponding author. Tel: +49 251 8345185; fax: +49 251 8345185, Email: kirchhp@uni-muenster.de
Journal : Europace   (2011)
Related Links: Pubmed | Publisher website
Pharmacological cardioversion of atrial fibrillation—a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously
Authors : Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N;
Affiliation : Department of Cardiology, Péterfy Hospital, Budapest, Hungary. Corresponding author. Tel: +46 31 776 1000; fax: +46 31 776 3737, Email: anders.r.berggren@astrazeneca.com
Journal : EP Europace   (2011)
Related Links: Pubmed | Publisher website

Ablation Specialist

Jafib
Powered by - Jafib Team   Privacy Policy | Site Map
hits counter